{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:40:47Z","timestamp":1759693247767,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.mehy.2020.109683","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T03:16:04Z","timestamp":1584587764000},"page":"109683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Hyperkalemic periodic paralysis aggravated by voltage - gate sodium channel blocker antiepileptic drug?"],"prefix":"10.1016","volume":"139","author":[{"given":"S.","family":"Zuki\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Sinanovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ale\u010dkovi\u0107-Halilovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Hod\u017ei\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Kova\u010devi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hod\u017ei\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.109683_b0005","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1212\/01.WNL.0000143383.91137.00","article-title":"Correlating phenotype and genotype in the periodic paralyses","volume":"63","author":"Miller","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2020.109683_b0010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.nurt.2007.02.001","article-title":"Genotype \u2013phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysis","volume":"4","author":"Jurkat-Rott","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.mehy.2020.109683_b0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ki.1996.2","article-title":"Periodic paralysis and voltage \u2013gated ion channels","volume":"49","author":"Fontaine","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.mehy.2020.109683_b0020","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1212\/01.WNL.0000145768.09934.EC","article-title":"New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis","volume":"63","author":"Vicart","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2020.109683_b0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0065-2660(08)01001-8","article-title":"Periodic paralysis","volume":"63","author":"Fontaine","year":"2008","journal-title":"Adv Genet"},{"key":"10.1016\/j.mehy.2020.109683_b0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000472351","article-title":"Mutations in the muscle sodium channel gene (SCN4A) in 13 French families with hyperkalemic periodic paralysis and paramyotonia congenita: Phenotype to genotype correlations and demonstration of the predominance of two mutations","volume":"2","author":"Plassart","year":"1994","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.mehy.2020.109683_b0035","first-page":"354","article-title":"A Met-to-Val mutation in the skeletal muscle Na+ channel alpha subunit in the hyperkalemic periodic paralysis","author":"Rojas","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2020.109683_b0040","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1126\/science.2173143","article-title":"Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-sbunit gene","volume":"250","author":"Fontaine","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.mehy.2020.109683_b0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/mus.880100414","article-title":"Adynamia episodica hereditaria with myotonia: a non inactivating sodium current and the effect of extracellular pH","volume":"10","author":"Lehmann-Horn","year":"1987","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.mehy.2020.109683_b0050","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1212\/WNL.58.8.1266","article-title":"Impairment of slow inactivation as a common mechanism for periodic paralysis in DIIS4-S5","volume":"58","author":"Bendahhou","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2020.109683_b0055","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0026-895X(25)12546-7","article-title":"Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells","volume":"27","author":"Willow","year":"1985","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.mehy.2020.109683_b0060","first-page":"S19","article-title":"Antiepileptic drug actions","volume":"30","author":"Rl","year":"1989","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.mehy.2020.109683_b0065","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.nmd.2013.02.007","article-title":"Long-term effectiveness of acetazolamide on permanent weakness in hyperkalemic periodic paralysis","volume":"23","author":"Dejthevaporn","year":"2013","journal-title":"Neuromuscul Disord"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720301870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720301870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:20:01Z","timestamp":1759692001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720301870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":13,"alternative-id":["S0306987720301870"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109683","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperkalemic periodic paralysis aggravated by voltage - gate sodium channel blocker antiepileptic drug?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109683","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109683"}}